EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024

Ulugbek Khudayberdievich Mirzaev iD, Jasur Ravshanovich Juraev iD, Iroda Pulatovna Sharipova, Sarvar Temurovich Islomov iD, Nodira Isroilovna Tursunova, Sitora Rakhmatova, Fatima Shokir Qizi Shodieva, Mirzarakhim Mirzakhakimovich Baynazarov iD, Khasanjon Kobiljon Ugli Odilov iD, Dilbar Yuldashevna Yuldasheva, Golib Abdulloyevich Khakimov

JNCI Cancer Spectrum · 2026

DOI: 10.1093/jncics/pkag107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Ulugbek Khudayberdievich Mirzaev und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Antimicrobial Resistance, National Biopharmaceutical Research Institute, Tashkent, Uzbekistan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Registries, Carcinoma in Situ. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer remains a leading cause of morbidity and mortality among women in Uzbekistan, exceeding WHO elimination targets. Despite a school-based HPV vaccination program launched in 2019, screening coverage remains low, leading to delayed diagnoses; we examined cervical cancer trends in Tashkent (2014-2024) to evaluate the impact of the Korea Foundation for International Healthcare (KOFIH) screening project and UNFPA/UNDP HPV testing initiatives.

Methods

We analyzed Tashkent City Oncoregister data for women diagnosed with invasive cervical cancer or carcinoma in situ (CIS) between 2014 and 2024 (n = 2140) after data cleaning. We calculated age-standardized incidence and mortality rates, assessed survival using Kaplan-Meier methods, and identified mortality predictors using Cox regression models.

Results

The age-standardized incidence of invasive cervical cancer was 14.9 per 100 000. After KOFIH and UNFPA/UNDP implementation, CIS diagnoses increased 3.4-fold (0.2-4.7 per 100 000), while the proportion of advanced-stage (III-IV) disease declined by 43%. Five-year survival showed clear stage dependence, ranging from 91.5% for CIS to 27.8% for stage IV. Age and stage were independent predictors of mortality. Crude mortality declined from 10.2 to 1.1 per 100 000 from 2014 to 2024, and case fatality decreased from 48.6% (2014-2019) to 27.2% (2020-2024).

Conclusion

Organized screening through KOFIH and UNFPA initiatives can improve early detection and reduce mortality. However, 76.6% of staged invasive cases remain advanced (II-IV), and more than 80% of women have never been screened, underscoring the need to expand screening, sustain HPV vaccination, and strengthen prevention programs in Central Asia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsRegistriesCarcinoma in SituFemaleHumansUzbekistanIncidenceMiddle AgedAdultPapillomavirus VaccinesPapillomavirus InfectionsAgedEarly Detection of CancerNeoplasm StagingKaplan-Meier EstimateSurvival RateYoung AdultProportional Hazards Models

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Microbiology and Antimicrobial Resistance, National Biopharmaceutical Research Institute, Tashkent, Uzbekistan.
  • Department of Life Sciences, Pharmaceutical Technical University, Tashkent, Uzbekistan.
  • Department of Preventive Service, Kyoto University, Kyoto, Japan.
  • Department of Oncology and Hematology, National Children's Medical Center, Tashkent, Uzbekistan.
  • Department of Oncology, Tashkent State Medical University, Tashkent, Uzbekistan.
  • Department of Treatment Management, Ministry of Health of Uzbekistan, Tashkent, Uzbekistan.

ORCID-Profile: Ulugbek Khudayberdievich Mirzaev, Jasur Ravshanovich Juraev, Sarvar Temurovich Islomov, Mirzarakhim Mirzakhakimovich Baynazarov, Khasanjon Kobiljon Ugli Odilov

Zitieren

APA

Mirzaev, U. K., Juraev, J. R., Sharipova, I. P., Islomov, S. T., Tursunova, N. I., Rakhmatova, S., Shodieva, F. S. Q., Baynazarov, M. M., Odilov, K. K. U., Yuldasheva, D. Y., & Khakimov, G. A. (2026). Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag107

Vancouver

Mirzaev UK, Juraev JR, Sharipova IP, Islomov ST, Tursunova NI, Rakhmatova S, et al. Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag107

BibTeX
@article{Mirzaev2026,
  author = {Mirzaev, Ulugbek Khudayberdievich and Juraev, Jasur Ravshanovich and Sharipova, Iroda Pulatovna and Islomov, Sarvar Temurovich and Tursunova, Nodira Isroilovna and Rakhmatova, Sitora and Shodieva, Fatima Shokir Qizi and Baynazarov, Mirzarakhim Mirzakhakimovich and Odilov, Khasanjon Kobiljon Ugli and Yuldasheva, Dilbar Yuldashevna and Khakimov, Golib Abdulloyevich},
  title = {Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  doi = {10.1093/jncics/pkag107}
}
Kostenlos starten →